Cargando…

Solid Cancer Treatment With Aurora Kinase Inhibitors: Towards a Personalized Medicine

Detalles Bibliográficos
Autor principal:	Ulisse, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704064/ https://www.ncbi.nlm.nih.gov/pubmed/29104076 http://dx.doi.org/10.1016/j.ebiom.2017.10.026

Ejemplares similares

Aurora kinase inhibitors: Progress towards the clinic
por: Kollareddy, Madhu, et al.
Publicado: (2012)

A New Aurora in Anaplastic Thyroid Cancer Therapy
por: Baldini, Enke, et al.
Publicado: (2014)

Aurora kinases shed light on resistance to EGFR inhibition in head and neck cancer
por: Kim, Donghwa, et al.
Publicado: (2021)

Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review
por: Gavriilidis, Paschalis, et al.
Publicado: (2015)

Towards personalized medicine – the role of methotrexate
por: Naik, Sita
Publicado: (2011)

Metabolomics: moving towards personalized medicine
por: Baraldi, Eugenio, et al.
Publicado: (2009)

Deregulated Expression of Aurora Kinases Is Not a Prognostic Biomarker in Papillary Thyroid Cancer Patients
por: Baldini, Enke, et al.
Publicado: (2015)

Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer?
por: Suda, Kenichi
Publicado: (2019)

Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
por: Stefani, Alessio, et al.
Publicado: (2022)

Aurora Kinase Inhibitors: Current Status and Outlook
por: Bavetsias, Vassilios, et al.
Publicado: (2015)

Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer
por: Gully, Christopher P, et al.
Publicado: (2010)

Aurora kinases in ovarian cancer
por: Pérez-Fidalgo, J Alejandro, et al.
Publicado: (2020)

Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine
por: Calzetta, Luigino, et al.
Publicado: (2017)

A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors
por: Mross, Klaus, et al.
Publicado: (2016)

Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor
por: Niu, Huifeng, et al.
Publicado: (2017)

Aurora kinase A, a synthetic lethal target for precision cancer medicine
por: Mou, Pui Kei, et al.
Publicado: (2021)

Towards personalized medicine in preterm newborns: Morphine analgesia predicted by genotype
por: Simons, Sinno.H.P.
Publicado: (2019)

A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors
por: de Groot, Christian O., et al.
Publicado: (2015)

Abscission checkpoint control: stuck in the middle with Aurora B
por: Carmena, Mar
Publicado: (2012)

Toward personalized inference on individual treatment effects
por: Chernozhukov, Victor, et al.
Publicado: (2023)

Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors
por: Falchook, Gerald S., et al.
Publicado: (2015)

High In Vitro and In Vivo Activity of BI-847325, a Dual MEK/Aurora Kinase Inhibitor, in Human Solid and Hematologic Cancer Models
por: Vuaroqueaux, Vincent, et al.
Publicado: (2023)

Evolution of Resistance to Aurora Kinase B Inhibitors in Leukaemia Cells
por: Failes, Timothy W., et al.
Publicado: (2012)

Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors
por: Cannon, Claire M, et al.
Publicado: (2013)

Dual roles of oxostephanine as an Aurora kinase inhibitor and angiogenesis suppressor
por: Tran, Thu-Hien Thi, et al.
Publicado: (2022)

Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells
por: Scharer, Christopher D, et al.
Publicado: (2008)

Prostate Cancer Claims for a Personalized Medicine
por: Lazzeri, Massimo
Publicado: (2015)

Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors: Small Steps Toward Personalized Medicine?
por: Ravegnini, Gloria, et al.
Publicado: (2019)

A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors
por: Dittrich, Christian, et al.
Publicado: (2014)

Aurora kinases: novel therapy targets in cancers
por: Tang, Anqun, et al.
Publicado: (2017)

Functions of Aurora kinase C in meiosis and cancer
por: Quartuccio, Suzanne M., et al.
Publicado: (2015)

Synthetic Strategies of Pyrimidine-Based Scaffolds as Aurora Kinase and Polo-like Kinase Inhibitors
por: Jadhav, Mrunal, et al.
Publicado: (2021)

Aurora at the pole and equator: overlapping functions of Aurora kinases in the mitotic spindle
por: Hochegger, Helfrid, et al.
Publicado: (2013)

Predictive Modeling of Drug Treatment in the Area of Personalized Medicine
por: Ogilvie, Lesley A., et al.
Publicado: (2015)

Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells
por: Tao, Y, et al.
Publicado: (2007)

Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib
por: Steeghs, Neeltje, et al.
Publicado: (2010)

The Discovery of Aurora Kinase Inhibitor by Multi-Docking-Based Virtual Screening
por: Kim, Jun-Tae, et al.
Publicado: (2014)

ABCG2 impairs the activity of the aurora kinase inhibitor tozasertib but not of alisertib
por: Michaelis, Martin, et al.
Publicado: (2015)

Phase separation of BuGZ promotes Aurora A activation and spindle assembly
por: Woodruff, Jeffrey B.
Publicado: (2018)

Aurora B Inhibitors as Cancer Therapeutics
por: Kovacs, Antal H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9kp38jpblia0i7p3rjp883j8af